Is There a Drug of Choice for Vasodilator Therapy in Patients with Refractory Heart Failure?

This publication has 12 references indexed in Scilit:

• Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.
  Circulation, 1979
• Relationship between initial systemic vascular resistance and the response to vasodilators in severe congestive heart failure
  The American Journal of Cardiology, 1979
• Hydralazine-Induced Tachycardia and Sodium Retention in Heart Failure
  Archives of internal medicine (1960), 1978
• Hydralazine-induced ischemia without tachycardia: The importance of coronary perfusion pressure gradients
  The American Journal of Cardiology, 1978
• Nitrate effects on cardiac output and left ventricular outflow resistance in chronic congestive heart failure
  The American Journal of Medicine, 1978
• Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction
  The American Journal of Cardiology, 1977
• Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: Prolonged effectiveness of isosorbide dinitrate
  The American Journal of Cardiology, 1977
• Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
  Circulation, 1977
• Sustained Reduction of Cardiac Impedance and Preload in Congestive Heart Failure with the Antihypertensive Vasodilator Prazosin
  New England Journal of Medicine, 1977
• Oral hydralazine therapy for chronic refractory heart failure.
  Circulation, 1976